Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 376-381

  El Gawad, Soma Sherif Abd ^a   El Kenawy, Fayez ^a   Mousa, Amany A ^a   Omar, Ashraf A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; GHRELIN; GLUCOSE; INSULIN; LIOTHYRONINE; RESISTIN; THYROTROPIN; THYROXINE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; MALE; PROTEIN BLOOD LEVEL; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WAIST HIP RATIO;

EID: 84861084250     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11130.OR     Document Type: Article

References (37)

1. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13: 18-23.
2. Sieminska L, Niedziolka D, Pillich A, et al. Serum concen-trations of adiponectin and resistin in hyperthyroid Graves' disease patients. J Endocrinol Invest. 2008;31:745-749.
3. Haugen F, Jørgensen A, Drevon C, Trayhurn P. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett. 2001;507:105-108.
4. Monzillo LU, Hamdy O, Horton ES, et al. Effect of life-style modification on adipokine levels in obese subjects with insulin resistance. Obes Res. 2003;11: 1048-1054.
5. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003;111:173-174.
6. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.
7. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghre-lin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.
8. Potenza M, Via MA, Yanagisawa RT. Excess thyroid hor-mone and carbohydrate metabolism. Endocr Pract. 2009; 15:254-262.
9. Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab. 2002;16:623-637.
10. Iglesias P, Diez JJ. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine. 2007;40:61-70.
11. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am. 1989;73:1-13.
12. Tietz NW. Clinical Guide to Laboratory Tests. 3rd ed. Philadelphia, PA: WB Saunders, 1995: 268-273.
13. Hwang DL, Barseghian G, Lev-Ran A. Determination of free insulin in antibody containing sera: Comparison of polyethylene glycol and staphylococcus aureus cells. Horm Metab Res. 1985;7:595-597.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assess-ment: Insulin resistance and beta-cell function from fast-ing plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
15. Keffer JH. Preanalytical considerations in testing thyroid function. Clin Chem. 1996;42:125-135.
16. Riis AL, Hansen TK, Møller N, Weeke J, Jørgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab. 2003;88:853-857.
17. On YK, Park HK, Hyon MS, Jeon ES. Serum resistin as a biological marker for coronary artery disease and resteno-sis in type 2 diabetic patients. Circ J. 2007;71:868-873.
18. Giménez-Palop O, Giménez-Pérez G, Mauricio D, et al. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthro-pometric changes. Eur J Endocrinol. 2005;153:73-79.
19. Bossowski A, Sawicka B, Szalecki M, Koput A, Wysocka J, Zelazowska-Rutkowska B. Analysis of serum adipo-nectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders. J Pediatric Endocrinol Metab. 2010;23:369-377.
20. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impairs insulin action on glucose production. J Clin Invest. 2003;111:225-230.
21. Braclik M, Marcisz C, Giebel S, Orzel A. Serum leptin and gherlin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Thyroid. 2008;18:545-550.
22. Loeb JN. Catecholamines and the sympathoadrenal sys-tem in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, PA: Lippencott Williams & Wilkins, 2000: 661-671.
23. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C. Influence of thyroid status and growth hor-mone deficiency on ghrelin. Eur J Endocrinol. 2002;147: 159-163.
24. Haqq AM, Farooqi IS, O'Rahilly S, et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are mark-edly increased in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003;88:174-178.
25. Altinova AE, Törüner FB, Aktürk M, et al. Reduced serum acylated gherlin levels in patients with hyperthyroid-ism. Horm Res. 2006;65:295-299.
26. O'Meara NM, Blackman JD, Sturis J, Polonksy KS. Alterations in the kinetics of C-peptide and insulin secre-tion in hyperthyroidism. J Clin Endocrinol Metab. 1993; 76:79-84.
27. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regu-lated by glucose or insulin: A double-blind, placebo-con-trolled crossover clamp study. Diabetes. 2003;52:16-20.
28. Loeb JN. Metabolic changes in thyrotoxicosis. In: Braveman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1996: 687-693.
29. Ciccarelli E, Zini M, Grottoli S, Razzore P, Portioli I, Valcavi R. Impaired prolactin response to arginine in patients with hyperthyroidism. Clin Endocrinol (Oxf). 1994;41:371-374.
30. Leoni MC, Pizzo D, Marchi A. Adipocytokines: Potential biomarkers for childhood obesity and anorexia nervosa [Article in Italian]. Minerva Pediatr. 2010;62:171-178.
31. Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf). 2002;56:203-206.
32. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145:669-673.
33. Iglesias P, Alvarez Fidalgo P, Codoceo R, Diez J. Serum concentration of adipocytokines in patients with hyperthy-roidism and hypothyroidism before and after control of thy-roid function. Clin Endocrinol (Oxf). 2003;59:621-629.
34. Yaturu S, Prado S, Grimes SR. Changes in adipocyte hor-mones leptin, resistin, and adiponectin in thyroid dysfunc-tion. J Cell Biochem. 2004;93:491-496.
35. Krassas CE, Pontikides N, Loustis K, Koliakos G, Constantinidis T, Panidis D. Resistin levels in hyperthy-roid patients before and after restoration of thyroid func-tion: Relationship with body weight and body composition. Eur J Endocrinol. 2005;153:217-221.
36. Wolfe BE, Jimerson DC, Orlova C, Mantzoro CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004;61:332-338.
37. Lee JH, Chan JL, Yiannakouris N, et al. Circulatory resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003;88: 4848-4856.